Drägerwerk 9M26 Sales Rise; EBIT Reaches €111.8M
Drägerwerk reported 9M26 net sales of €2.454 billion versus approximately €2.344 billion a year earlier, and EBIT of €111.8 million versus approximately €77.1 million. Order intake rose to €2.674 billion; the company reaffirmed its 2026 outlook for FX-adjusted sales growth of 2%–6% and an EBIT margin of 6%–8%.
Drägerwerk AG & Co. KGaA posted 9M26 net sales of €2.454B (≈€2.344B prior) and EBIT of €111.8M (≈€77.1M), aided by €27.9M customs refunds. Order intake rose to €2.674B. 2026 outlook reaffirmed: sales +2% to +6% (fx-adj.) and EBIT margin 6%—8%.Material DetailsContext by AI AnalystThis is a mid-cycle…